Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancersRania El Botty, Elisabetta Marangoni|Nature Communications|2023Cited by 96
<i>HORMAD1</i> overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancersRania El Botty, Elisabetta Marangoni|Molecular Oncology|2023Cited by 9